Functional analysis of the common haplotype in the receptor for advanced glycation end-products gene previously identified as a susceptibility factor for diabetic nephropathy
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
Yan SF, Du Yan S, Ramasamy R, etal. Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med 2009 1-15
Haplotype analysis of the RAGE gene: Identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
Kankova K, Stejskalova A, Hertlova M, etal. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 2005 20 1093-1102
Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach
Kankova K, Stejskalova A, Pacal L, etal. Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. Diabetologia 2007 50 990-999
Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products
Li J, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997 272 16498-16506
Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy
Hudson BI, Stickland MH, Futers TS, etal. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001 50 1505-1511
Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene
Kanková K, Kalousová M, Hertlová M, etal. Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene. Arch Physiol Biochem 2008 114 111-119